Cargando…
Retraction: The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
Autores principales: | Wu, Wei, Yu, Li-hua, Ma, Bei, Xu, Ming-juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147763/ https://www.ncbi.nlm.nih.gov/pubmed/32275702 http://dx.doi.org/10.1371/journal.pone.0231890 |
Ejemplares similares
-
The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2014) -
Retracted: FTX Regulated miR-153-3p/FOXR2 to Promote Cisplatin Resistance in Ovarian Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction]
Publicado: (2023)